SILO PHARMA INC (SILO) Stock Balance Sheet
NASDAQ:SILO - Nasdaq - US82711P2011 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 4.86M | 3.52M | 11.37M | 9.84M | 1.13M | |||
| Marketable Securities | 3.15M | 4.14M | 0.00 | 420.00K | 0.00 | |||
| Receivables | N/A | 0.00 | 70.00K | 0.00 | 20.00K | |||
| Inventories | N/A | N/A | N/A | 0.00 | 30.00K | |||
| Other Current Assets | 246.45K | 15.97K | 140.00K | 150.00K | 240.00K | |||
| Total Current Assets | 8.26M | 7.68M | 11.57M | 10.40M | 1.43M | |||
| Non-Current Assets | ||||||||
| Intangibles | 244.31K | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 60.60K | 64.98K | 70.00K | 30.00K | N/A | |||
| Total Non-Current Assets | 304.91K | 64.98K | 70.00K | 90.00K | 0.00 | |||
| TOTAL ASSETS | 8.57M | 7.75M | 11.64M | 10.49M | 1.43M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | 0.00 | 10.00K | |||
| Accounts Payable | 972.73K | 703.49K | 360.00K | 420.00K | 130.00K | |||
| Other Current Liabilities | 72.10K | 72.10K | 70.00K | 70.00K | N/A | |||
| Total Current Liabilities | 1.04M | 775.59K | 440.00K | 490.00K | 140.00K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 739.60K | 793.68K | 870.00K | 940.00K | N/A | |||
| Total Non-Current Liabilities | 739.61K | 793.68K | 860.00K | 940.00K | 10.00K | |||
| TOTAL LIABILITIES | 1.78M | 1.57M | 1.30M | 1.43M | 150.00K | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -13.53M | -10.87M | -7.17M | -3.26M | -5.76M | |||
| Additional Paid In Capital | 20.30M | 17.53M | 17.51M | 12.31M | 7.03M | |||
| Common Shares | 450.00 | 320.00 | 0.00 | 10.00K | 10.00K | |||
| Treasury Stock | -6.27K | -471.12K | N/A | N/A | N/A | |||
| Other Shareholders' Equity | 19.80K | -6.23K | N/A | N/A | N/A | |||
| Shares Outstanding | 4.48M | 2.91M | 3.16M | 1.97M | 1.70M | |||
| Tangible Book Value per Share | 1.46 | 2.13 | 3.27 | 4.60 | 0.75 | |||
| Total Shareholders' Equity | 6.78M | 6.18M | 10.34M | 9.06M | 1.28M | |||
| TOTAL LIABILITIES AND EQUITY | 8.57M | 7.75M | 11.64M | 10.49M | 1.43M | |||
| Statistics | ||||||||
| Current Ratio | 7.91 | 9.90 | 26.30 | 21.22 | 10.21 | |||
| Return On Assets (ROA) | -44.16% | -47.77% | -33.59% | 23.83% | -217.48% | |||
| Return On Equity (ROE) | -55.78% | -59.91% | -37.81% | 27.59% | -242.97% | |||
All data in USD , ROIC based on taxRate of 0.21